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scheduled control in 41/45 patients. At all scheduled controls shrinkage was statistically
significant. The mean size of 41 lesions evaluated at presentation, one, six and twelve
months follow up was 34.12 mm (9-80, SD15.52), 29.93 mm (6-70, SD14.86), 29.10
mm (6-70, SD14.96) and 26.88 (6-63, SD15.39) respectively. Diameter reduction rate
was 15.5%, 3.8% and 11% at 1, 6 and 12 months (statistically significant: p0.05).
Presence of mural thrombus did not influence shrinkage timing (p0.05), while complex
lesion anatomy (presence of side branches) delay shrinkage (p0.05).
Conclusions: data at one year FU show that CMPS is an effective device for repair of
PAA and VAA with/without collateral branches, with significant shrinkage of the sac,
allowing a broader group of patients to be treated with endovascular repair with results
comparable to other traditional endovascular technique.
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Background: To present angiographic and clinical results of a retrospective registry
assessing the performance of a biodegradable polymer-based Biolimus A9-eluting stent
(BES) in the treatment of focal below the knee atherosclerotic disease.
Methods: From 05/2009 to 05/2011, 25 patients (17 men; mean age 71.8  6.7 years)
with chronic lower limb ischemia (Rutherford categories 3-6) underwent primary BES
placement in focal infrapopliteal lesions. Dual antiplatelet theraphy (DAPT) was pre-
scribed for six month. The primary endpoint was freedom from angiographic in-stent
stenosis (ISRS) 50%. Clinical endpoints were death, amputation, and bypass surgery.
Results were correlated with patient and lesion characteristics and cumulative outcomes
were assessed with Kaplan-Meier analysis.
Results: Technical success was achieved in all cases. Freedom from ISRS were 100 %
after 6 months, 96.0% after 12 months, and 92.0% at 12 months. No stent occlusions
occurred. During clinical follow-up of 25 patients over a mean 14 6 months, there were
no deaths, no mayor amputations, and no need for bypass surgery. Clinical status
improved in all the patients.
Conclusions: Treatment of focal infrapopliteal lesions with BES showed encouraging
angiographic results in this registry. Clinical improvement was robust and particualry
evident in CLI patients. Six months of DAPT were sufficient to prevent stent thrombosis.
Further studies are needed to evaluate the potential clinical benefit of BES as compared
to balloon angioplasty or bare metal stents in the treatment of infrapopliteal lesions.
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Background: The endovascular treatment of patients with critical limb ischemia (CLI)
is complex and poorly studied. Plaque excision allows the debulking of the atherosclerotic
plaque without the need of leaving a foreign body behind. The DEFINITIVE LE study
was a global study that assessed the effectiveness of plaque excision using the Silver-
Hawk® and TurboHawkTM Systems (Covidien/ev3, Plymouth, MN) for PAD in
femoropopliteal and tibial-peroneal arteries with specific evaluation of patients with
claudication and CLI.
Methods: The DEFINITIVE LE study enrolled 200 patients (278 lesions) with CLI who
underwent revascularization with plaque excision. . Endpoints were assessed by indepen-
dent core laboratories. The primary endpoint for CLI patients was freedom from major
unplanned amputation of the target limb at 1 year.
Results: In 200 patients in the DEFINITIVE LE study with CLI, mean age was 72.1
years, 50% were male, and 69.0% had diabetes. Other frequent comorbidities included
hypertension (92.5%), hyperlipidemia (76.5%) and renal insufficiency (24.0%). The mean
lesion length was 7.1 cm and 24.5% of lesions were 10 cm. The mean baseline stenosis
was 75.8% and 36.8% of lesions were calcified. At 6 months and at 1 year, freedom from
amputation was 97.3% and 95.8%,. Primary patency was 86.9% at 6 months and 69.2%
at 1 year. Other secondary endpoints demonstrated significant, sustained improvements as
shown below.
Outcome Baseline
3-Month
Follow-Up
6-Month
Follow-Up
12-Month
Follow-Up
Rutherford Clinical
Category
RCC 4 37.00% n/a 2.10% 5.30%
RCC 5 53.00% n/a 21.00% 14.30%
RCC 6 10.00% n/a 5.60% 4.50%
Ankle-Brachial
Index
0.59 0.18 n/a 0.70 0.26 0.78 0.26
EQ-5D Score 0.64 0.22 n/a 0.74 0.21 0.74 0.21
EQ-5D Visual
Analog
60.2 20.8 n/a 68.3 19.2 70.2 18.1
Wound Healing
(Wagner scale)
0 1.80% 51.70% 62.40% 72.20%
1 54.60% 25.00% 28.60% 17.40%
2 19.60% 10.00% 3.00% 4.30%
3 6.10% 5.00% 1.50% 0.90%
4 16.00% 6.70% 4.50% 1.70%
5 1.80% 1.70% 0.00% 3.50%
Conclusions: Plaque excision for CLI results in high rates of limb salvage and good
primary patency at 1 year, as well as improvements in wound healing, clinical status as
measured by RCC and ABI, and improved quality of life for this challenging patient
population. This was accomplished with a very low rate of stent use which would allow
for future intervention with new technology that may be excluded if a stent were in place.
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Background: Catheter-based renal artery denervation has been successfully introduced
as alternative treatment for patients suffering from drug-resistant essential hypertension.
However, the local morphological changes within the vessel wall accompanying this
technique remain elusive and we sought to characterize these by utilizing the Simplicity®
(Medtronic Ardian, Mountain View, CA, USA) radiofrequency catheter approach.
Methods: Following treatment of seven pigs, renal arteries were assigned to either the
acute (n6), sub-acute (10-day follow-up, n6) or control (untreated, n2) group. At
follow-up blood analysis, final angiography and optical coherence tomography (OCT)-
imaging of the treated arteries were performed and renal arteries and kidneys were
processed for histopathology and immunohistochemistry.
Results: Radiofrequency derived energy application to the vessel wall induced transmu-
ral tissue coagulation and loss of endothelium resulting in local thrombus formation also
detectable by OCT. At 10 days, the luminal surface was almost completely re-
endothelialized. Mural wall damage was replaced by fibrotic tissue and the adventitial
layer showed strong inflammatory infiltration including vasculogenesis. Remnant auto-
nomic nerve fascicles within the lesion segments of the sub-acute group displayed
enhanced vacuolic degeneration and an impaired neurofilament protein immunostaining
pattern. Examination of the kidneys revealed no abnormalities and blood parameters
remained within the physiological range.
Conclusions: Catheter-based application of radiofrequency energy resulted in circum-
scribed transmural injury within the arterial wall affecting autonomic nerve fascicles in a
delayed manner. Acute loss of endothelialization resulted in thrombus formation leaving
kidney perfusion unimpaired.
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